NCT04322539 · BASELINE
Baseline characteristics
Results reported by the registry submitting party. Population, time horizon, units and missing values must be read together.
- denoms
- counts
- group Id
- BG000
- value
- 461
- group Id
- BG001
- value
- 230
- group Id
- BG002
- value
- 691
- units
- Participants
- groups
- description
- Participants received 5 mg of fruquintinib oral capsule in combination with BSC once daily for 3 weeks of continuous dosing followed by a 1-week break during a treatment cycle (Each cycle length was 28 days).
- id
- BG000
- title
- Fruquintinib + BSC Group
- description
- Participants received placebo matched to fruquintinib oral capsule in combination with BSC once daily for 3 weeks of continuous dosing followed by a 1-week break during a treatment cycle (Each cycle length was 28 days).
- id
- BG001
- title
- Placebo + BSC Group
- description
- Total of all reporting groups
- id
- BG002
- title
- Total
- measures
- classes
- categories
- measurements
- group Id
- BG000
- spread
- 10.41
- value
- 62.2
- group Id
- BG001
- spread
- 9.67
- value
- 62.4
- group Id
- BG002
- spread
- 10.16
- value
- 62.2
- dispersion Type
- STANDARD_DEVIATION
- param Type
- MEAN
- title
- Age, Continuous
- unit Of Measure
- years
- classes
- categories
- measurements
- group Id
- BG000
- value
- 216
- group Id
- BG001
- value
- 90
- group Id
- BG002
- value
- 306
- title
- Female
- measurements
- group Id
- BG000
- value
- 245
- group Id
- BG001
- value
- 140
- group Id
- BG002
- value
- 385
- title
- Male
- param Type
- COUNT_OF_PARTICIPANTS
- title
- Sex: Female, Male
- unit Of Measure
- Participants
- classes
- categories
- measurements
- group Id
- BG000
- value
- 20
- group Id
- BG001
- value
- 14
- group Id
- BG002
- value
- 34
- title
- Hispanic or Latino
- measurements
- group Id
- BG000
- value
- 405
- group Id
- BG001
- value
- 202
- group Id
- BG002
- value
- 607
- title
- Not Hispanic or Latino
- measurements
- group Id
- BG000
- value
- 36
- group Id
- BG001
- value
- 14
- group Id
- BG002
- value
- 50
- title
- Unknown or Not Reported
- param Type
- COUNT_OF_PARTICIPANTS
- title
- Ethnicity (NIH/OMB)
- unit Of Measure
- Participants
- classes
- categories
- measurements
- group Id
- BG000
- value
- 0
- group Id
- BG001
- value
- 1
- group Id
- BG002
- value
- 1
- title
- American Indian or Alaska Native
- measurements
- group Id
- BG000
- value
- 43
- group Id
- BG001
- value
- 18
- group Id
- BG002
- value
- 61
- title
- Asian
- measurements
- group Id
- BG000
- value
- 13
- group Id
- BG001
- value
- 7
- group Id
- BG002
- value
- 20
- title
- Black or African American
- measurements
- group Id
- BG000
- value
- 3
- group Id
- BG001
- value
- 2
- group Id
- BG002
- value
- 5
- title
- Native Hawaiian or Other
- measurements
- group Id
- BG000
- value
- 367
- group Id
- BG001
- value
- 192
- group Id
- BG002
- value
- 559
- title
- White
- measurements
- group Id
- BG000
- value
- 5
- group Id
- BG001
- value
- 2
- group Id
- BG002
- value
- 7
- title
- Other
- measurements
- group Id
- BG000
- value
- 2
- group Id
- BG001
- value
- 0
- group Id
- BG002
- value
- 2
- title
- Multiple races
- measurements
- group Id
- BG000
- value
- 28
- group Id
- BG001
- value
- 8
- group Id
- BG002
- value
- 36
- title
- Not reported/unknown
- title
- Race
- param Type
- COUNT_OF_PARTICIPANTS
- title
- Race/Ethnicity, Customized
- unit Of Measure
- Participants
- population Description
- Intent-to-Treat (ITT) population included all randomized participants.
Complete source fields
- denoms
- counts
- group Id
- BG000
- value
- 461
- group Id
- BG001
- value
- 230
- group Id
- BG002
- value
- 691
- units
- Participants
- groups
- description
- Participants received 5 mg of fruquintinib oral capsule in combination with BSC once daily for 3 weeks of continuous dosing followed by a 1-week break during a treatment cycle (Each cycle length was 28 days).
- id
- BG000
- title
- Fruquintinib + BSC Group
- description
- Participants received placebo matched to fruquintinib oral capsule in combination with BSC once daily for 3 weeks of continuous dosing followed by a 1-week break during a treatment cycle (Each cycle length was 28 days).
- id
- BG001
- title
- Placebo + BSC Group
- description
- Total of all reporting groups
- id
- BG002
- title
- Total
- measures
- classes
- categories
- measurements
- group Id
- BG000
- spread
- 10.41
- value
- 62.2
- group Id
- BG001
- spread
- 9.67
- value
- 62.4
- group Id
- BG002
- spread
- 10.16
- value
- 62.2
- dispersion Type
- STANDARD_DEVIATION
- param Type
- MEAN
- title
- Age, Continuous
- unit Of Measure
- years
- classes
- categories
- measurements
- group Id
- BG000
- value
- 216
- group Id
- BG001
- value
- 90
- group Id
- BG002
- value
- 306
- title
- Female
- measurements
- group Id
- BG000
- value
- 245
- group Id
- BG001
- value
- 140
- group Id
- BG002
- value
- 385
- title
- Male
- param Type
- COUNT_OF_PARTICIPANTS
- title
- Sex: Female, Male
- unit Of Measure
- Participants
- classes
- categories
- measurements
- group Id
- BG000
- value
- 20
- group Id
- BG001
- value
- 14
- group Id
- BG002
- value
- 34
- title
- Hispanic or Latino
- measurements
- group Id
- BG000
- value
- 405
- group Id
- BG001
- value
- 202
- group Id
- BG002
- value
- 607
- title
- Not Hispanic or Latino
- measurements
- group Id
- BG000
- value
- 36
- group Id
- BG001
- value
- 14
- group Id
- BG002
- value
- 50
- title
- Unknown or Not Reported
- param Type
- COUNT_OF_PARTICIPANTS
- title
- Ethnicity (NIH/OMB)
- unit Of Measure
- Participants
- classes
- categories
- measurements
- group Id
- BG000
- value
- 0
- group Id
- BG001
- value
- 1
- group Id
- BG002
- value
- 1
- title
- American Indian or Alaska Native
- measurements
- group Id
- BG000
- value
- 43
- group Id
- BG001
- value
- 18
- group Id
- BG002
- value
- 61
- title
- Asian
- measurements
- group Id
- BG000
- value
- 13
- group Id
- BG001
- value
- 7
- group Id
- BG002
- value
- 20
- title
- Black or African American
- measurements
- group Id
- BG000
- value
- 3
- group Id
- BG001
- value
- 2
- group Id
- BG002
- value
- 5
- title
- Native Hawaiian or Other
- measurements
- group Id
- BG000
- value
- 367
- group Id
- BG001
- value
- 192
- group Id
- BG002
- value
- 559
- title
- White
- measurements
- group Id
- BG000
- value
- 5
- group Id
- BG001
- value
- 2
- group Id
- BG002
- value
- 7
- title
- Other
- measurements
- group Id
- BG000
- value
- 2
- group Id
- BG001
- value
- 0
- group Id
- BG002
- value
- 2
- title
- Multiple races
- measurements
- group Id
- BG000
- value
- 28
- group Id
- BG001
- value
- 8
- group Id
- BG002
- value
- 36
- title
- Not reported/unknown
- title
- Race
- param Type
- COUNT_OF_PARTICIPANTS
- title
- Race/Ethnicity, Customized
- unit Of Measure
- Participants
- population Description
- Intent-to-Treat (ITT) population included all randomized participants.
Download exact source JSON → · Snapshot ctgov-results-191f4516d4760045304b24a0
Preserved source evidence · Independent clinical review pending · Not medical advice
Triangle